Home HIV FAQ My Amedeo About Flying Publisher   

Amedeo Prize 2008
The 21 Finalists


  Hyperlipoproteinemias

  Free Subscription


Articles published in Am J Cardiol

Retrieve available abstracts of 57 articles:
HTML format



Single Articles


    April 2008
  1. BARAC A , Campia U, Matuskey LA, Lu L, et al
    Effects of peroxisome proliferator-activated receptor-gamma activation with pioglitazone on plasma adipokines in nondiabetic patients with either hypercholesterolemia or hypertension.
    Am J Cardiol. 2008;101:980-5.
    PubMed     Related articles    Abstract available


    February 2008
  2. KAPOOR JR
    Postprandial hyperglycemia: are all sulfonylureas created equal?
    Am J Cardiol. 2008;101:554-5.
    PubMed     Related articles   


  3. ATHYROS VG , Tziomalos K, Kakafika AI, Koumaras H, et al
    Effectiveness of ezetimibe alone or in combination with twice a week Atorvastatin (10 mg) for statin intolerant high-risk patients.
    Am J Cardiol. 2008;101:483-5.
    PubMed     Related articles    Abstract available


  4. AI M , Otokozawa S, Asztalos BF, Nakajima K, et al
    Effects of maximal doses of atorvastatin versus rosuvastatin on small dense low-density lipoprotein cholesterol levels.
    Am J Cardiol. 2008;101:315-8.
    PubMed     Related articles    Abstract available


    December 2007
  5. EHARA S , Naruko T, Kobayashi Y, Kataoka T, et al
    Comparison of clinical characteristics and arterial remodeling by intravascular ultrasonic imaging in three age groups (</=55, 56 to 69 and >/=70 years) of Japanese patients with acute myocardial infarction.
    Am J Cardiol. 2007;100:1713-7.
    PubMed     Related articles    Abstract available


    November 2007
  6. ALSHEIKH-ALI AA , Lin JL, Abourjaily P, Ahearn D, et al
    Prevalence of low high-density lipoprotein cholesterol in patients with documented coronary heart disease or risk equivalent and controlled low-density lipoprotein cholesterol.
    Am J Cardiol. 2007;100:1499-501.
    PubMed     Related articles    Abstract available


  7. STEIN EA , Amerena J, Ballantyne CM, Brice E, et al
    Long-Term Efficacy and Safety of Rosuvastatin 40 mg in Patients With Severe Hypercholesterolemia.
    Am J Cardiol. 2007;100:1387-96.
    PubMed     Related articles    Abstract available   Free Full Text


  8. OPOLE IO , Belmont JM, Kumar A, Moriarty PM, et al
    Effect of low-density lipoprotein apheresis on inflammatory and noninflammatory high-density lipoprotein cholesterol.
    Am J Cardiol. 2007;100:1416-8.
    PubMed     Related articles    Abstract available


    October 2007
  9. BETTERIDGE DJ , Gibson JM, Sager PT
    Comparison of Effectiveness of Rosuvastatin Versus Atorvastatin on the Achievement of Combined C-Reactive Protein (<2 mg/L) and Low-Density Lipoprotein Cholesterol (<70 mg/dl) Targets in Patients With Type 2 Diabetes Mellitus (from the ANDROMEDA St
    Am J Cardiol. 2007;100:1245-8.
    PubMed     Related articles    Abstract available


  10. YE ZX , Cheng HM, Chiou KR, Huang PH, et al
    Relation of Coronary Artery Calcium to Flow-Mediated Dilation and C-Reactive Protein Levels in Asymptomatic Patients With Heterozygous Familial Hypercholesterolemia.
    Am J Cardiol. 2007;100:1119-1123.
    PubMed     Related articles    Abstract available


    September 2007
  11. O'KEEFE JH , Bell DS
    Postprandial hyperglycemia/hyperlipidemia (postprandial dysmetabolism) is a cardiovascular risk factor.
    Am J Cardiol. 2007;100:899-904.
    PubMed     Related articles    Abstract available


  12. CAMPBELL CY , Nasir K, Sarwar A, Meneghelo RS, et al
    Combined effect of high low-density lipoprotein cholesterol and metabolic syndrome on subclinical coronary atherosclerosis in white men without clinical evidence of myocardial ischemia.
    Am J Cardiol. 2007;100:840-3.
    PubMed     Related articles    Abstract available


  13. ZHAO D , Grundy SM, Wang W, Liu J, et al
    Ten-year cardiovascular disease risk of metabolic syndrome without central obesity in middle-aged chinese.
    Am J Cardiol. 2007;100:835-9.
    PubMed     Related articles    Abstract available


    August 2007
  14. KARALIS DG , Ishisaka DY, Luo D, Ntanios F, et al
    Effects of increasing doses of atorvastatin on the atherogenic lipid subclasses commonly associated with hypertriglyceridemia.
    Am J Cardiol. 2007;100:445-9.
    PubMed     Related articles    Abstract available


  15. BACKES JM , Moriarty PM, Ruisinger JF, Gibson CA, et al
    Effects of once weekly rosuvastatin among patients with a prior statin intolerance.
    Am J Cardiol. 2007;100:554-5.
    PubMed     Related articles    Abstract available


    July 2007
  16. RAJAGOPALAN S , Zannad F, Radauceanu A, Glazer R, et al
    Effects of valsartan alone versus valsartan/simvastatin combination on ambulatory blood pressure, C-reactive protein, lipoproteins, and monocyte chemoattractant protein-1 in patients with hyperlipidemia and hypertension.
    Am J Cardiol. 2007;100:222-6.
    PubMed     Related articles    Abstract available


  17. KOSTIS JB
    Treating hypercholesterolemia and hypertension based on lifetime global risk.
    Am J Cardiol. 2007;100:138-42.
    PubMed     Related articles   


    June 2007
  18. GINSBERG HN , Bonds DE, Lovato LC, Crouse JR, et al
    Evolution of the Lipid Trial Protocol of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial.
    Am J Cardiol. 2007;99.
    PubMed     Related articles    Abstract available


  19. GILLESPIE MJ , Davis CJ, Lambert ND, Costello FM, et al
    Measuring and treating serum lipids in patients in a chest pain observation unit.
    Am J Cardiol. 2007;99:1718-20.
    PubMed     Related articles    Abstract available


  20. PEARSON T , Ballantyne C, Sisk C, Shah A, et al
    Comparison of effects of ezetimibe/simvastatin versus simvastatin versus atorvastatin in reducing C-reactive protein and low-density lipoprotein cholesterol levels.
    Am J Cardiol. 2007;99:1706-1713.
    PubMed     Related articles    Abstract available


  21. FRIEDEWALD VE , Gheorghiade M, Yancy CW, Young JB, et al
    The Editor's Roundtable: Acute Decompensated Heart Failure.
    Am J Cardiol. 2007;99:1560-7.
    PubMed     Related articles   


  22. DEEDWANIA PC , Gupta M, Stein M, Ycas J, et al
    Comparison of Rosuvastatin Versus Atorvastatin in South-Asian Patients at Risk of Coronary Heart Disease (from the IRIS Trial).
    Am J Cardiol. 2007;99:1538-43.
    PubMed     Related articles    Abstract available


    May 2007
  23. CASO G , Kelly P, McNurlan MA, Lawson WE, et al
    Effect of coenzyme q10 on myopathic symptoms in patients treated with statins.
    Am J Cardiol. 2007;99:1409-12.
    PubMed     Related articles    Abstract available


  24. MAINOUS AG 3RD , Koopman RJ, Diaz VA, Everett CJ, et al
    A coronary heart disease risk score based on patient-reported information.
    Am J Cardiol. 2007;99:1236-41.
    PubMed     Related articles    Abstract available


    March 2007
  25. ASZTALOS BF , Le Maulf F, Dallal GE, Stein E, et al
    Comparison of the effects of high doses of rosuvastatin versus atorvastatin on the subpopulations of high-density lipoproteins.
    Am J Cardiol. 2007;99:681-5.
    PubMed     Related articles    Abstract available


  26. BALLANTYNE CM , Weiss R, Moccetti T, Vogt A, et al
    Efficacy and Safety of Rosuvastatin 40 mg Alone or in Combination With Ezetimibe in Patients at High Risk of Cardiovascular Disease (Results from the EXPLORER Study).
    Am J Cardiol. 2007;99:673-80.
    PubMed     Related articles    Abstract available


    February 2007
  27. LLOYD-JONES DM , Dyer AR, Wang R, Daviglus ML, et al
    Risk factor burden in middle age and lifetime risks for cardiovascular and non-cardiovascular death (chicago heart association detection project in industry).
    Am J Cardiol. 2007;99:535-40.
    PubMed     Related articles    Abstract available   Free Full Text


  28. ST-PIERRE J , Lemieux I, Perron P, Brisson D, et al
    Relation of the "hypertriglyceridemic waist" phenotype to earlier manifestations of coronary artery disease in patients with glucose intolerance and type 2 diabetes mellitus.
    Am J Cardiol. 2007;99:369-73.
    PubMed     Related articles    Abstract available


    January 2007
  29. MACKIE BD , Satija S, Nell C, Miller J 3rd, et al
    Monday, Wednesday, and Friday dosing of rosuvastatin in patients previously intolerant to statin therapy.
    Am J Cardiol. 2007;99:291.
    PubMed     Related articles    Abstract available


  30. SHAPIRO H , Bruck R
    Omega-3 may indirectly reduce hepatocyte triglycerides through modulation of hyperinsulinemia, cytokines and adipocytokines.
    Am J Cardiol. 2007;99:146.
    PubMed     Related articles   


  31. ITO MK , Marrs J, Williams C
    Omacor effects on serum lipids and clinical outcome.
    Am J Cardiol. 2007;99:145.
    PubMed     Related articles   


  32. DEFARIA YEH D , Freeman MW, Meigs JB, Grant RW, et al
    Risk factors for coronary artery disease in patients with elevated high-density lipoprotein cholesterol.
    Am J Cardiol. 2007;99:1-4.
    PubMed     Related articles    Abstract available


    November 2006
  33. ROBINSON JG , Stone NJ
    Identifying patients for aggressive cholesterol lowering: the risk curve concept.
    Am J Cardiol. 2006;98:1405-8.
    PubMed     Related articles    Abstract available


  34. NAWAZ H , Comerford BP, Njike VY, Dhond AJ, et al
    Repeated serum lipid measurements during the peri-hospitalization period.
    Am J Cardiol. 2006;98:1379-82.
    PubMed     Related articles    Abstract available


  35. RAVIPATI G , Aronow WS, Ahn C, Channamsetty V, et al
    Incidence of new stroke or new myocardial infarction or death in patients with severe carotid arterial disease treated with and without statins.
    Am J Cardiol. 2006;98:1170-1.
    PubMed     Related articles    Abstract available


    October 2006
  36. MESSERLI FH , Bangalore S, Egan BM, Julius S, et al
    Does life-long reduction in low-density lipoprotein cholesterol reduce the risk of new-onset hypertension?
    Am J Cardiol. 2006;98:1122.
    PubMed     Related articles   


  37. PANZA F , Capurso C, Solfrizzi V
    Cardiovascular factors and cognitive impairment: a role for unsaturated Fatty acids and mediterranean diet?
    Am J Cardiol. 2006;98:1120-1.
    PubMed     Related articles   


  38. SAKAI K , Nakagawa Y, Soga Y, Ando K, et al
    Comparison of 30-day outcomes in patients <75 years of age versus >/=75 years of age with acute myocardial infarction treated by primary coronary angioplasty.
    Am J Cardiol. 2006;98:1018-21.
    PubMed     Related articles    Abstract available


  39. COOPER-DEHOFF R , Cohen JD, Bakris GL, Messerli FH, et al
    Predictors of Development of Diabetes Mellitus in Patients With Coronary Artery Disease Taking Antihypertensive Medications (Findings from the INternational VErapamil SR-Trandolapril STudy [INVEST]).
    Am J Cardiol. 2006;98:890-4.
    PubMed     Related articles    Abstract available


    September 2006
  40. LLORET R , Ycas J, Stein M, Haffner S, et al
    Comparison of Rosuvastatin Versus Atorvastatin in Hispanic-Americans With Hypercholesterolemia (from the STARSHIP Trial).
    Am J Cardiol. 2006;98:768-73.
    PubMed     Related articles    Abstract available


  41. DEVARAJ S , Autret B, Jialal I
    Effects of Colesevelam Hydrochloride (WelChol) on Biomarkers of Inflammation in Patients With Mild Hypercholesterolemia.
    Am J Cardiol. 2006;98:641-3.
    PubMed     Related articles    Abstract available


  42. SOROKIN AV , Duncan B, Panetta R, Thompson PD, et al
    Rhabdomyolysis associated with pomegranate juice consumption.
    Am J Cardiol. 2006;98:705-6.
    PubMed     Related articles    Abstract available


    August 2006
  43. BAYS H
    Clinical overview of Omacor: a concentrated formulation of omega-3 polyunsaturated fatty acids.
    Am J Cardiol. 2006;98.
    PubMed     Related articles    Abstract available


  44. REIFFEL JA , McDonald A
    Antiarrhythmic effects of omega-3 fatty acids.
    Am J Cardiol. 2006;98.
    PubMed     Related articles    Abstract available


  45. SINGH M , Lennon RJ, Roger VL, Rihal CS, et al
    Relation of preprocedural statin therapy to in-hospital procedural complications following percutaneous coronary interventions in patients with hyperlipidemia.
    Am J Cardiol. 2006;98:325-30.
    PubMed     Related articles    Abstract available


  46. CHENG TO
    Prevalence of metabolic syndrome in Chinese adults has been underestimated by using US-Based National Cholesterol Education Programs Adult Treatment Panel III and World Health Organization criteria.
    Am J Cardiol. 2006;98:422-3.
    PubMed     Related articles   


    July 2006
  47. WONG ND , Lopez V, Tang S, Williams GR, et al
    Prevalence, treatment, and control of combined hypertension and hypercholesterolemia in the United States.
    Am J Cardiol. 2006;98:204-8.
    PubMed     Related articles    Abstract available


  48. MEYERS CD , McCarren M, Wong ND, Abraira C, et al
    Baseline Achievement of Lipid Goals and Usage of Lipid Medications in Patients With Diabetes Mellitus (from the Veterans Affairs Diabetes Trial).
    Am J Cardiol. 2006;98:63-5.
    PubMed     Related articles    Abstract available


    June 2006
  49. KLONER RA , Jackson G, Hutter AM, Mittleman MA, et al
    Cardiovascular Safety Update of Tadalafil: Retrospective Analysis of Data from Placebo-Controlled and Open-Label Clinical Trials of Tadalafil With As Needed, Three Times-per-Week or Once-a-Day Dosing.
    Am J Cardiol. 2006;97:1778-84.
    PubMed     Related articles    Abstract available


  50. CROUSE JR 3RD , Elam MB, Robinson JG, Ambrosius WT, et al
    Cholesterol management: targeting a lower low-density lipoprotein cholesterol concentration increases adult treatment panel-III goal attainment.
    Am J Cardiol. 2006;97:1667-9.
    PubMed     Related articles   


  51. VIDT DG , Harris S, McTaggart F, Ditmarsch M, et al
    Effect of short-term rosuvastatin treatment on estimated glomerular filtration rate.
    Am J Cardiol. 2006;97:1602-6.
    PubMed     Related articles    Abstract available


    May 2006
  52. RUBINSHTEIN R , Halon DA, Jaffe R, Shahla J, et al
    Relation between obesity and severity of coronary artery disease in patients undergoing coronary angiography.
    Am J Cardiol. 2006;97:1277-80.
    PubMed     Related articles    Abstract available


    April 2006
  53. BAYS HE , Davidson M, Jones MR, Abby SL, et al
    Effects of colesevelam hydrochloride on low-density lipoprotein cholesterol and high-sensitivity C-reactive protein when added to statins in patients with hypercholesterolemia.
    Am J Cardiol. 2006;97:1198-205.
    PubMed     Related articles    Abstract available


  54. NASH DT , Fillit H
    Cardiovascular disease risk factors and cognitive impairment.
    Am J Cardiol. 2006;97:1262-5.
    PubMed     Related articles    Abstract available


  55. TANEVA E , Borucki K, Wiens L, Makarova R, et al
    Early effects on endothelial function of atorvastatin 40 mg twice daily and its withdrawal.
    Am J Cardiol. 2006;97:1002-6.
    PubMed     Related articles    Abstract available


    March 2006
  56. WOJNICZ R , Wilczek K, Nowalany-Kozielska E, Szygula-Jurkiewicz B, et al
    Usefulness of atorvastatin in patients with heart failure due to inflammatory dilated cardiomyopathy and elevated cholesterol levels.
    Am J Cardiol. 2006;97:899-904.
    PubMed     Related articles    Abstract available


  57. SIMON JA , Lin F, Hulley SB, Blanche PJ, et al
    Phenotypic predictors of response to simvastatin therapy among African-Americans and Caucasians: the Cholesterol and Pharmacogenetics (CAP) Study.
    Am J Cardiol. 2006;97:843-50.
    PubMed     Related articles    Abstract available


Thank you for your interest in scientific medicine.


Amedeo is a Bernd Sebastian Kamps website.

   Design: